Skip to main content

Table 3 Association of initial levels of oxidative stress markers with endpoints

From: Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia

Entire Cohort (n = 278)

Adverse outcome at 30d

6 year Mortality

OR (95% CI); p-value

HR (95% CI); p-value

Tyrosinea

 Univariate

3.30 (0.63 to 17.36), p = 0.159

1.88 (0.90 to 3.91), p = 0.093

 Multivariateb

0.84 (0.15 to 4.65), p = 0.841

1.58 (0.72 to 3.47), p = 0.256

 AUROC

0.55 (0.44 to 0.66)

0.60 (0.54 to 0.67)

Tyr-NO2a

 Univariate

0.65 (0.35 to 1.20), p = 0.167

0.96 (0.73 to 1.27), p = 0.778

 Multivariateb

0.44 (0.20 to 0.96), p = 0.039

0.81 (0.6 to 1.1), p = 0.181

 AUROC

0.43 (0.31 to 0.56)

0.50 (0.42 to 0.58)

Ratio Tyr-NO2/Tyrosine

 Univariate

0.91 (0.81 to 1.02), p = 0.098

0.99 (0.95 to 1.02), p = 0.457

 Multivariateb

0.98 (0.97 to 0.99), p = 0.043

1.00 (0.99 to 1.00), p = 0.216

 AUROC

0.42 (0.30 to 0.53)

0.48 (0.40 to 0.56)

  1. aValues were log-transformed; b Multivariate analysis adjusted for PSI-Class (≤3 vs ≥4) BMI and comorbidities